Search For "study on leukaemia"
Three-medicine combination therapy is beneficial in patients with high-ris
Updated : 3 years, 3 months ago IST
According to a new, phase 2 clinical trial led by Dana-Farber Cancer Institute doctors, a three-medicine combination that drove chronic lymphocytic leukaemia (CLL) patients into profound remissions in a clinical study is very beneficial in patients with high-risk variants of the disease.
Read More